COMMUNIQUÉS West-GlobeNewswire
-
Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors
11/06/2026 -
BiomX: Zorronet’s AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global Events
11/06/2026 -
Arizona Nonprofit Launches “America 250” Fundraiser Featuring 250 Winners to Support Childhood Blindness Research
11/06/2026 -
Parexel to Highlight Expertise Across Eight Thought Leadership Sessions at 2026 DIA Global Annual Meeting
11/06/2026 -
Sharecare wins 14 Digital Health Awards in Spring 2026 competition
11/06/2026 -
Palisade Bio Welcomes Biopharmaceutical Industry Veterans Robert Baltera and Jordan Zwick to its Board of Directors
11/06/2026 -
Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management
11/06/2026 -
Spectral AI to Participate in 2026 British Burn Association Annual Conference
11/06/2026 -
Alpha Tau Receives FDA Clearance to Complete Enrollment in REGAIN Recurrent Glioblastoma Trial and Add Two U.S. Clinical Sites; Early Interim Results Showed 100% Local Disease Control
11/06/2026 -
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
11/06/2026 -
VVT Med Expands into the Dominican Republic, Appointing Antilles Medical as Exclusive Distributor
11/06/2026 -
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
11/06/2026 -
Dentsply Sirona Appoints John Fortson as Chief Financial Officer
11/06/2026 -
Zevra’s Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition
11/06/2026 -
Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing
11/06/2026 -
CytoDyn Announces First Patient Dosed in Phase 2a Study in Collaboration with Weill Cornell Medicine Evaluating Leronlimab in Alzheimer’s Disease
11/06/2026 -
Imviva Biotech Presents Studies on CTD402 Allogeneic CAR-T Therapy at EHA2026 Congress
11/06/2026 -
Propanc Biopharma Authorizes $5.0 Million Share Repurchase Program
11/06/2026 -
TOMI Environmental Solutions Highlights Massive Biosecurity Opportunity Ahead of FIFA World Cup
11/06/2026
Pages